Nagy, A.C.; Tóth, Á.; Bak, N.; Ulambayar, B.; Ghanem, A.S.; Sztanek, F.
Protective Influence of SGLT-2 Inhibitors Against Heart Failure in Type 2 Diabetes Mellitus Through Longitudinal Clinical Database Analysis. J. Clin. Med. 2024, 13, 7093.
https://doi.org/10.3390/jcm13237093
AMA Style
Nagy AC, Tóth Á, Bak N, Ulambayar B, Ghanem AS, Sztanek F.
Protective Influence of SGLT-2 Inhibitors Against Heart Failure in Type 2 Diabetes Mellitus Through Longitudinal Clinical Database Analysis. Journal of Clinical Medicine. 2024; 13(23):7093.
https://doi.org/10.3390/jcm13237093
Chicago/Turabian Style
Nagy, Attila Csaba, Ágnes Tóth, Natália Bak, Battamir Ulambayar, Amr Sayed Ghanem, and Ferenc Sztanek.
2024. "Protective Influence of SGLT-2 Inhibitors Against Heart Failure in Type 2 Diabetes Mellitus Through Longitudinal Clinical Database Analysis" Journal of Clinical Medicine 13, no. 23: 7093.
https://doi.org/10.3390/jcm13237093
APA Style
Nagy, A. C., Tóth, Á., Bak, N., Ulambayar, B., Ghanem, A. S., & Sztanek, F.
(2024). Protective Influence of SGLT-2 Inhibitors Against Heart Failure in Type 2 Diabetes Mellitus Through Longitudinal Clinical Database Analysis. Journal of Clinical Medicine, 13(23), 7093.
https://doi.org/10.3390/jcm13237093
